ReviewFrontiers in cardiovascular medicine2022

Risk Factors for the Comorbidity of Hypertension and Renal Cell Carcinoma in the Cardio-Oncologic Era and Treatment for Tumor-Induced Hypertension.

Zhengqing Ba et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.